| Identification | More | [Name]
Ginsenoside Rh2 | [CAS]
78214-33-2 | [Synonyms]
(3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl beta-d-glucopyranoside
GINSENOSIDE RH2
dihydroxydammar-24-en-3-yl
β-D-Glucopyranoside, (3β,12β)-12,20-
R-form-Ginsenoside Rh2
12β,20-Dihydroxy-5α-dammar-24-en-3β-yl β-D-glucopyranoside
3β-(β-D-Glucopyranosyloxy)dammara-24-ene-12β,20-diol | [Molecular Formula]
C36H62O8 | [MDL Number]
MFCD00800712 | [Molecular Weight]
622.87 | [MOL File]
78214-33-2.mol |
| Chemical Properties | Back Directory | [Melting point ]
139-144 °C | [Boiling point ]
726.4±60.0 °C(Predicted) | [density ]
1.19±0.1 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,2-8°C | [solubility ]
DMF: 10 mg/ml; DMSO: 10 mg/ml; DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml | [form ]
neat | [pka]
12.91±0.70(Predicted) | [color ]
White | [Detection Methods]
NMR,HPLC | [InChIKey]
CKUVNOCSBYYHIS-IRFFNABBSA-N | [LogP]
5.620 (est) | [CAS DataBase Reference]
78214-33-2(CAS DataBase Reference) |
| Hazard Information | Back Directory | [Description]
Ginsenoside Rh2 is a steroid glycoside found in plants of the genus Panax that has diverse biological activities.1,2,3,4,5 It inhibits release of β-hexosaminidase from RBL-2H3 cells (IC50 = 100 μM) and inhibits the IgE-dependent passive cutaneous anaphylaxis reaction in mice at a dose of 25 mg/kg.1 It inhibits growth of HRA ovarian and BxPC-3 pancreatic cancer cells in a dose-dependent manner.3,4 In vivo, ginsenoside Rh2 decreases immobility time in the forced swim test in a mouse model of colorectal carcinoma.5 Ginsenoside Rh2 also reduces infarct volume in a rat model of ischemia-reperfusion-induced brain injury.2 | [Chemical Properties]
White solid | [Uses]
20(S)-Ginsenoside Rh2 is a bioactive metabolite of the ginsenoside component of Panax ginseng that has been shown to exhibit antibacterial effects in vitro. | [Definition]
ChEBI: A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 3
has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. |
|
|